| Cannabinoid CB2 receptors: immunohistochemical localization in rat brain JP Gong, ES Onaivi, H Ishiguro, QR Liu, PA Tagliaferro, A Brusco, GR Uhl Brain research 1071 (1), 10-23, 2006 | 1037 | 2006 |
| Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain ES Onaivi, H Ishiguro, JP GONG, S Patel, A Perchuk, PA Meozzi, L Myers, ... Annals of the New York Academy of Sciences 1074 (1), 514-536, 2006 | 696 | 2006 |
| Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects ES Onaivi, H Ishiguro, JP Gong, S Patel, PA Meozzi, L Myers, A Perchuk, ... PLoS one 3 (2), e1640, 2008 | 324 | 2008 |
| Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by … QR Liu, CH Pan, A Hishimoto, CY Li, ZX Xi, A Llorente‐Berzal, ... Genes, Brain and Behavior 8 (5), 519-530, 2009 | 318 | 2009 |
| Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse PW Zhang, H Ishiguro, T Ohtsuki, J Hess, F Carillo, D Walther, ES Onaivi, ... Molecular psychiatry 9 (10), 916-931, 2004 | 317 | 2004 |
| Identification of a polymorphism in the promoter region of DRD4associated with the human novelty seeking personality trait Y Okuyama, H Ishiguro, M Nankai, H Shibuya, A Watanabe, T Arinami Molecular psychiatry 5 (1), 64-69, 2000 | 273 | 2000 |
| A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia Y Okuyama, H Ishiguro, M Toru, T Arinami Biochemical and biophysical research communications 258 (2), 292-295, 1999 | 230 | 1999 |
| Cannabis sativa L.-botany and biotechnology S Chandra, H Lata, MA ElSohly Springer, 2017 | 227 | 2017 |
| Brain cannabinoid CB2 receptor in schizophrenia H Ishiguro, Y Horiuchi, M Ishikawa, M Koga, K Imai, Y Suzuki, M Morikawa, ... Biological psychiatry 67 (10), 974-982, 2010 | 225 | 2010 |
| Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression ES Onaivi, H Ishiguro, JP Gong, S Patel, PA Meozzi, L Myers, A Perchuk, ... Annals of the new York Academy of Sciences 1139 (1), 434-449, 2008 | 221 | 2008 |
| CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity ES Onaivi, H Ishiguro, S Gu, QR Liu Journal of psychopharmacology 26 (1), 92-103, 2012 | 211 | 2012 |
| Association between serotonin transporter gene polymorphism and smoking among Japanese males H Ishikawa, T Ohtsuki, H Ishiguro, K Yamakawa-Kobayashi, K Endo, ... Cancer Epidemiology Biomarkers & Prevention 8 (9), 831-833, 1999 | 159 | 1999 |
| Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans H Ishiguro, S Iwasaki, L Teasenfitz, S Higuchi, Y Horiuchi, T Saito, ... The pharmacogenomics journal 7 (6), 380-385, 2007 | 149 | 2007 |
| Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference QR Liu, A Canseco-Alba, HY Zhang, P Tagliaferro, M Chung, E Dennis, ... Scientific reports 7 (1), 17410, 2017 | 147 | 2017 |
| Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia M Koga, H Ishiguro, S Yazaki, Y Horiuchi, M Arai, K Niizato, S Iritani, ... Human molecular genetics 18 (13), 2483-2494, 2009 | 140 | 2009 |
| Endocannabinoids and cannabinoid receptor genetics ES Onaivi, CM Leonard, H Ishiguro, PW Zhang, Z Lin, BE Akinshola, ... Progress in neurobiology 66 (5), 307-344, 2002 | 137 | 2002 |
| Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism S Ueno, M Nakamura, M Mikami, K Kondoh, H Ishiguro, T Arinami, ... Molecular psychiatry 4 (6), 552-557, 1999 | 134 | 1999 |
| Association Study Between the 441C Ins/Del and TaqI A Polymorphisms of the Dopamine D2 Receptor Gene and Alcoholism H Ishiguro, T Arinami, T Saito, S Akazawa, M Enomoto, H Mitushio, ... Alcoholism: Clinical and Experimental Research 22 (4), 845-848, 1998 | 120 | 1998 |
| Polymorphisms in genes involved in neurotransmission in relation to smoking T Arinami, H Ishiguro, ES Onaivi European journal of pharmacology 410 (2-3), 215-226, 2000 | 118 | 2000 |
| Pathway-based association analysis of genome-wide screening data suggest that genes associated with the γ-aminobutyric acid receptor signaling pathway are involved in … T Inada, M Koga, H Ishiguro, Y Horiuchi, A Syu, T Yoshio, N Takahashi, ... Pharmacogenetics and Genomics 18 (4), 317-323, 2008 | 115 | 2008 |
